BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mesci P, Macia A, Moore SM, Shiryaev SA, Pinto A, Huang CT, Tejwani L, Fernandes IR, Suarez NA, Kolar MJ, Montefusco S, Rosenberg SC, Herai RH, Cugola FR, Russo FB, Sheets N, Saghatelian A, Shresta S, Momper JD, Siqueira-Neto JL, Corbett KD, Beltrão-Braga PCB, Terskikh AV, Muotri AR. Blocking Zika virus vertical transmission. Sci Rep 2018;8:1218. [PMID: 29352135 DOI: 10.1038/s41598-018-19526-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 da Silva S, Oliveira Silva Martins D, Jardim ACG. A Review of the Ongoing Research on Zika Virus Treatment. Viruses 2018;10:E255. [PMID: 29758005 DOI: 10.3390/v10050255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
2 Han Y, Mesplède T. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update. Expert Opin Investig Drugs 2018;27:951-62. [PMID: 30430882 DOI: 10.1080/13543784.2018.1548609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
3 Masmejan S, Baud D, Musso D, Panchaud A. Zika virus, vaccines, and antiviral strategies. Expert Rev Anti Infect Ther 2018;16:471-83. [PMID: 29897831 DOI: 10.1080/14787210.2018.1483239] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Gardinali NR, Marchevsky RS, Oliveira JM, Pelajo-Machado M, Kugelmeier T, Castro MP, Silva ACA, Pinto DP, Fonseca LB, Vilhena LS, Pereira HM, Lima SMB, Miranda EH, Trindade GF, Linhares JHR, Silva SA, Melgaço JG, Alves AMB, Moran J, Silva MCC, Soares-Bezerra RJ, Soriano A, Bentes GA, Bottino FO, Salvador Castro Faria SB, Nudelman RF, Lopes CAA, Perea JAS, Sarges K, Andrade MCR, Motta MCVA, Freire MS, Souza TML, Schmidt-Chanasit J, Pinto MA. Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys. Antiviral Res 2020;182:104859. [PMID: 32649965 DOI: 10.1016/j.antiviral.2020.104859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Willner MJ, Xiao Y, Kim HS, Chen X, Xu B, Leong KW. Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids. J Tissue Eng 2021;12:2041731420985299. [PMID: 33738089 DOI: 10.1177/2041731420985299] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Benazzato C, Russo FB, Beltrão-Braga PCB. An update on preclinical pregnancy models of Zika virus infection for drug and vaccine discovery. Expert Opin Drug Discov 2021;:1-7. [PMID: 34461793 DOI: 10.1080/17460441.2021.1973999] [Reference Citation Analysis]
7 Dragoni F, Boccuto A, Picarazzi F, Giannini A, Giammarino F, Saladini F, Mori M, Mastrangelo E, Zazzi M, Vicenti I. Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. Antiviral Res 2020;175:104708. [PMID: 31931104 DOI: 10.1016/j.antiviral.2020.104708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
8 Bernatchez JA, Coste M, Beck S, Wells GA, Luna LA, Clark AE, Zhu Z, Hecht D, Rich JN, Sohl CD, Purse BW, Siqueira-Neto JL. Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells. Viruses 2019;11:E365. [PMID: 31010044 DOI: 10.3390/v11040365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Yang S, Gorshkov K, Lee EM, Xu M, Cheng YS, Sun N, Soheilian F, de Val N, Ming G, Song H, Tang H, Zheng W. Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation. Front Microbiol 2020;11:598203. [PMID: 33424801 DOI: 10.3389/fmicb.2020.598203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Vicenti I, Zazzi M, Saladini F. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19. Expert Opin Ther Pat 2021;31:325-37. [PMID: 33475441 DOI: 10.1080/13543776.2021.1880568] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
11 Muotri AR. Brain organoids and insights on human evolution. F1000Res 2019;8:F1000 Faculty Rev-760. [PMID: 31275562 DOI: 10.12688/f1000research.18495.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Yang S, Xu M, Lee EM, Gorshkov K, Shiryaev SA, He S, Sun W, Cheng YS, Hu X, Tharappel AM, Lu B, Pinto A, Farhy C, Huang CT, Zhang Z, Zhu W, Wu Y, Zhou Y, Song G, Zhu H, Shamim K, Martínez-Romero C, García-Sastre A, Preston RA, Jayaweera DT, Huang R, Huang W, Xia M, Simeonov A, Ming G, Qiu X, Terskikh AV, Tang H, Song H, Zheng W. Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry. Cell Discov 2018;4:31. [PMID: 29872540 DOI: 10.1038/s41421-018-0034-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 16.5] [Reference Citation Analysis]
13 Pomar L, Musso D, Malinger G, Vouga M, Panchaud A, Baud D. Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome. Prenat Diagn 2019;39:420-30. [PMID: 30866073 DOI: 10.1002/pd.5446] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
14 Li B, Liao HM, Liu H, Tsai S, Zhang J, Hung GC, Chin PJ, Gao Y, Lo SC. Comparative genomics, infectivity and cytopathogenicity of Zika viruses produced by acutely and persistently infected human hematopoietic cell lines. PLoS One 2018;13:e0203331. [PMID: 30192813 DOI: 10.1371/journal.pone.0203331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 [DOI: 10.1101/2020.05.30.125856] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
16 Caine EA, Jagger BW, Diamond MS. Animal Models of Zika Virus Infection during Pregnancy. Viruses 2018;10:E598. [PMID: 30384472 DOI: 10.3390/v10110598] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
17 Zein AFMZ, Sulistiyana CS, Raffaello WM, Wibowo A, Pranata R. Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment. Postgrad Med J 2021:postgradmedj-2021-140287. [PMID: 34103373 DOI: 10.1136/postgradmedj-2021-140287] [Reference Citation Analysis]
18 Gupta N, Kodan P, Baruah K, Soneja M, Biswas A. Zika virus in India: past, present and future. QJM 2019:hcz273. [PMID: 31642501 DOI: 10.1093/qjmed/hcz273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Qiao L, Martelli CMT, Raja AI, Sanchez Clemente N, de Araùjo TVB, Ximenes RAA, Miranda-Filho DB, Ramond A, Brickley EB. Epidemic preparedness: Prenatal Zika virus screening during the next epidemic. BMJ Glob Health 2021;6:e005332. [PMID: 34117012 DOI: 10.1136/bmjgh-2021-005332] [Reference Citation Analysis]
20 Pastuch-Gawołek G, Gillner D, Król E, Walczak K, Wandzik I. Selected nucleos(t)ide-based prescribed drugs and their multi-target activity. Eur J Pharmacol 2019;865:172747. [PMID: 31634460 DOI: 10.1016/j.ejphar.2019.172747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
21 Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R. Drugs for the Treatment of Zika Virus Infection. J Med Chem 2020;63:470-89. [PMID: 31549836 DOI: 10.1021/acs.jmedchem.9b00775] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
22 Yao G, Yu J, Lin C, Zhu Y, Duan A, Li M, Yuan J, Zhang J. Design, synthesis, and biological evaluation of novel 2′-methyl-2′-fluoro-6-methyl-7-alkynyl-7-deazapurine nucleoside analogs as anti-Zika virus agents. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114275] [Reference Citation Analysis]
23 Christian KM, Song H, Ming GL. Pathophysiology and Mechanisms of Zika Virus Infection in the Nervous System. Annu Rev Neurosci 2019;42:249-69. [PMID: 31283901 DOI: 10.1146/annurev-neuro-080317-062231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
24 Ohki CMY, Benazzato C, Russo FB, Beltrão-Braga PCB. Developing animal models of Zika virus infection for novel drug discovery. Expert Opin Drug Discov 2019;14:577-89. [PMID: 30991850 DOI: 10.1080/17460441.2019.1597050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Trujillo CA, Muotri AR. Brain Organoids and the Study of Neurodevelopment. Trends Mol Med 2018;24:982-90. [PMID: 30377071 DOI: 10.1016/j.molmed.2018.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
26 Gorshkov K, Shiryaev SA, Fertel S, Lin YW, Huang CT, Pinto A, Farhy C, Strongin AY, Zheng W, Terskikh AV. Zika Virus: Origins, Pathological Action, and Treatment Strategies. Front Microbiol 2018;9:3252. [PMID: 30666246 DOI: 10.3389/fmicb.2018.03252] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
27 Mercorelli B, Palù G, Loregian A. Drug Repurposing for Viral Infectious Diseases: How Far Are We? Trends Microbiol 2018;26:865-76. [PMID: 29759926 DOI: 10.1016/j.tim.2018.04.004] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 26.0] [Reference Citation Analysis]